Dr. Vitanza is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4800 Sand Point Way Ne
Seattle, WA 98105- Is this information wrong?
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Pediatric Neuro-Oncology, 2014 - 2016
- NYU Grossman School of MedicineFellowship, Pediatric Hematology/Oncology, 2011 - 2014
- Stony Brook Medicine/University HospitalResidency, Pediatrics, 2008 - 2011
- American University of the Caribbean School of MedicineClass of 2008
Certifications & Licensure
- CA State Medical License 2014 - Present
- WA State Medical License 2016 - 2025
- ID State Medical License 2021 - 2024
- AK State Medical License 2021 - 2022
- NY State Medical License 2011 - 2019
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Young Investigator Travel Stipend Award American Society of Pediatric Hematology/Oncology, 2014
- Research Training Award for Fellows American Society of Hematology, 2013
Clinical Trials
- ONC201 in Pediatric H3 K27M Gliomas Start of enrollment: 2018 Jan 29
- HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors Start of enrollment: 2018 Jul 26
Publications & Presentations
PubMed
- CAR T cell therapies for diffuse midline glioma.Bryce C Thomas, Dilana E Staudt, Alicia M Douglas, Michelle Monje, Nicholas A Vitanza, Matthew D Dun> ;Trends in Cancer. 2023 Oct 1
- 54 citationsIntraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety.Nicholas A Vitanza, Ashley L Wilson, Wenjun Huang, Kristy Seidel, Christopher Brown, Joshua A Gustafson, Jason K Yokoyama, Adam J Johnson, Blake A Baxter, Ryan W Konin...> ;Cancer Discovery. 2023 Jan 9
- 12 citationsPhase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy.Sharon L Gardner, Rohinton S Tarapore, Jeffrey Allen, Susan L McGovern, Wafik Zaky, Yazmin Odia, Doured Daghistani, Zuanel Diaz, Matthew D Hall, Ziad Khatib, Carl Kosc...> ;Neuro-Oncology Advances. 2022 Sep 13
- Join now to see all
Press Mentions
- Novel Approaches to Malignant Brain Tumor Treatment Aim to Overcome Familiar ChallengesJanuary 27th, 2022
- AeroPress Grants Cancer Research Award to Dr. Nicholas VitanzaMarch 24th, 2021
- Trials Underway Using Experimental CAR T-cell Therapy for Deadly Childhood Brain CancerNovember 5th, 2020
- Join now to see all
Grant Support
- Research Training Award for FellowsAmerican Society of Hematology2013–2014
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: